Table 2.
Immunoglobulin A anti-tissue transglutaminase seropositivity in patients with liver disease and patients who underwent liver transplantation
| IgA anti-tTG seropositivity | Diagnosis | M/F | n (%) |
| Liver disease | Wilson’s disease | 1/3 | 4 (12.9) |
| Autoimmune hepatitis type I | 1/4 | 5 (6.5) | |
| Primary biliary cirrhosis | 0/1 | 1 (3.1) | |
| Budd-Chiari syndrome | 0/1 | 1 (7.1) | |
| Mild hepatic liver tests abnormalities | 5/2 | 7 (20) | |
| Liver steatosis | 3/1 | 4 (3.3) | |
| Viral hepatitis B | 1/0 | 1 (0.9) | |
| Toxic hepatitis | 1/0 | 1 (4.8) | |
| Nonalcoholic steatohepatitis | 0/2 | 2 (8.7) | |
| Primary sclerosing cholangitis | 1/1 | 2 (3.4) | |
| Polycystic liver | 0/1 | 1 (10) | |
| OLTx | Wilson’s disease | 1/1 | 2 (6.9) |
| Autoimmune hepatitis type I | 0/2 | 2 (6.1) | |
| Alcoholic liver cirrhosis | 1/0 | 1 (0.6) |
IgA: Immunoglobulin A; tTG: Tissue transglutaminase; OLTx: Patients who underwent liver transplantation; M/F: Male/female.